glp 1 agonists mechanism of action GLP-1 Receptor as Treatments for Type 2 Diabetes Recent updates on GLP-1 agonists:
Description
[DOI] [PubMed] [Google Scholar] 72.Pasternak B., Wintzell V., Hviid A., et al
( Epub 20231228 )
Dipeptidyl peptidase-4 inhibitor use is associated with decreased risk of fracture in patients with type 2 diabetes: a population-based cohort study
It is estimated that about 415 million people had diabetes in 2015, and this number may continue to rise to 642 million by 2040
doi:10.1001/jamanetworkopen.2025.26321,
On GLP-1 medications where you might already struggle with reduced fluid intake , this is especially important to remember
